SIRT6 inhibits metastasis by suppressing SNAIL expression in nasopharyngeal carcinoma cells

Feng Chen1,2,3, Xiaofeng Ma2,3, Yongze Liu2,3

  • 1Department of Otorhinolaryngology-Head and Neck Surgery, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University China.

Insights

SIRT6 suppresses nasopharyngeal carcinoma (NPC) metastasis by epigenetically silencing SNAIL. This finding reveals SIRT6 as a potential therapeutic target for reducing NPC spread and improving patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Nasopharyngeal carcinoma (NPC) is an aggressive head and neck cancer known for local invasion and early metastasis.
  • SIRT6 is implicated in various cancers, but its role in NPC metastasis is unclear.

Purpose of the Study:

  • To investigate the role and mechanism of SIRT6 in regulating nasopharyngeal carcinoma cell metastasis.
  • To determine the association between SIRT6 expression and NPC metastatic potential.

Main Methods:

  • Comparative analysis of SIRT6 expression in high and low metastatic NPC cell lines (5-8F and 6-10B).
  • Investigation of SIRT6's interaction with transcription factor p65 (NF-kB subunit).
  • Assessment of SIRT6-mediated epigenetic modification (deacetylation) at the SNAIL promoter (H3K9 and H3K56).

Main Results:

  • SIRT6 expression is inversely correlated with NPC cell metastatic capability.
  • SIRT6 inhibits NPC cell metastasis by suppressing SNAIL expression.
  • SIRT6 deacetylates H3K9 and H3K56 at the SNAIL promoter, reducing its transcription.

Conclusions:

  • SIRT6 acts as a metastasis suppressor in nasopharyngeal carcinoma.
  • Epigenetic regulation of SNAIL by SIRT6 is a key mechanism inhibiting NPC metastasis.
  • Targeting SIRT6 may offer a novel therapeutic strategy for NPC treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.4K